OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This will be a double blind, randomised, 4 arm, parallel group, placebo controlled study of
three dose levels of OC000459 tablets in patients with asthma controlled by beta agonist
drugs alone. This study will compare the patients on OC000459 at three different dose levels
(25mg once daily, 100mg twice daily and 200mg once daily) with patients on placebo after
dosing for 17 weeks. The trial will be undertaken in an outpatient population. Each treatment
arm will consist of at least 110 subjects. The objective is to assess the efficacy of these
dose levels on the patients asthma.